A simple course of antibiotics for a throat infection. A paracetamol tablet for fever. An anti-seizure medication prescribed for epilepsy. These are medicines millions of Indians take every day without a second thought. But for a small number of people, one of these routine prescriptions triggers a catastrophic immune reaction that causes the skin to blister, peel away, and slough off in sheets — a condition called Stevens-Johnson Syndrome (SJS). It is rare, it is terrifying, and in India, it is more common than most people realise.
Research published in the Indian Journal of Dermatology, Venereology and Leprology (IJDVL) estimates the mortality rate for SJS in India at approximately 3.9%, rising to a staggering 28.2% when it progresses to its severe form, Toxic Epidermal Necrolysis (TEN). An 8-year study found an incidence rate of 622 cases per million population — significantly higher than global averages. Yet awareness among ordinary Indians remains dangerously low. Understanding SJS could save your life or the life of someone you love.
What Is Stevens-Johnson Syndrome?
Stevens-Johnson Syndrome (SJS) is a severe, potentially life-threatening hypersensitivity reaction, most commonly triggered by medications. It primarily affects the skin and mucous membranes — the moist linings of the mouth, eyes, throat, and genitals. The immune system, responding abnormally to a drug, attacks the skin cells, causing them to die and separate from the layers beneath.
SJS exists on a severity spectrum:
| Classification | Body Surface Area (BSA) Affected | Severity |
|---|---|---|
| SJS | Less than 10% | Serious |
| SJS-TEN Overlap | 10% – 30% | Very serious |
| TEN (Toxic Epidermal Necrolysis) | More than 30% | Life-threatening |
When skin detachment exceeds 30% of the body surface, the condition is reclassified as TEN, which carries a mortality rate of over 28% in Indian studies. Think of it as a spectrum — SJS and TEN are the same disease process at different levels of severity, much like a first-degree burn versus a third-degree burn.
Which Drugs Cause SJS in India?
In over 97% of Indian cases, SJS is triggered by a drug. A landmark multicentric retrospective analysis of drug-induced SJS across Indian hospitals identified the most common culprit medications:
Most Common Drug Categories
| Drug Category | Percentage of Cases | Common Examples |
|---|---|---|
| Antibiotics / Antimicrobials | 37.3% | Fluoroquinolones, Sulfonamides, Cotrimoxazole |
| Anti-epileptic drugs | 35.7% | Carbamazepine (Tegretol, Zen Retard), Phenytoin (Eptoin, Dilantin) |
| NSAIDs / Analgesics | 15.9% | Paracetamol (Crocin, Dolo), Ibuprofen (Brufen), Piroxicam |
| Antiretrovirals | Significant in HIV+ patients | Nevirapine (Nevimune), Cotrimoxazole |
Individual Drugs Most Commonly Implicated
| Drug | Percentage | Common Indian Brands |
|---|---|---|
| Carbamazepine | 18.3% | Tegretol, Zen Retard, Mazetol |
| Phenytoin | 13.4% | Eptoin, Dilantin |
| Fluoroquinolones | 8.5% | Ciprofloxacin (Ciplox), Levofloxacin (Levoflox) |
| Paracetamol | 6.2% | Crocin, Dolo 650, Calpol |
| Sulfonamides | 6.2% | Septran, Bactrim |
Regional Variations Across India
Interestingly, the most common culprit drug varies by region. Research shows that carbamazepine is the most frequent trigger in South India, phenytoin dominates in North India, and paracetamol is the leading cause in West India. This regional variation may reflect prescribing patterns, genetic differences, and the prevalence of conditions like epilepsy in different populations.
Important: The fact that common, over-the-counter drugs like paracetamol and fluoroquinolone antibiotics appear on this list is precisely why awareness matters. These are not exotic medications — they are medicines found in practically every Indian household's medicine box.
Recognising the Symptoms of SJS
SJS typically begins 1-3 weeks after starting a new medication, though it can occur even after weeks of tolerating a drug. The early symptoms are deceptively ordinary, mimicking a common flu, which is why SJS is frequently missed in its initial stages.
Early Warning Signs (Days 1-3)
- Unexplained fever (often above 38°C / 100.4°F)
- Sore throat and difficulty swallowing
- Burning, red eyes with sensitivity to light
- Body aches and general malaise
- Cough and respiratory discomfort
Progression (Days 3-5)
- Painful red or purple patches appearing on the skin, often starting on the face and trunk
- Blisters forming on the skin that burst easily
- Target-like lesions — flat, irregularly shaped spots with darker centres
- Painful sores developing inside the mouth, making eating and drinking extremely difficult
- Eye involvement — redness, discharge, and a gritty sensation
- Swelling and blistering of the lips
- Skin becoming tender to touch — even a bedsheet brushing against it causes pain
When to Seek Emergency Medical Care
If you or a family member has recently started a new medication and develops any combination of the above symptoms — especially fever with skin rash and mouth sores — go to a hospital emergency department immediately. SJS is a medical emergency. Do not wait to "see if it gets better." Early identification and stopping the offending drug is the single most important factor in survival.
The Genetic Connection: HLA-B*1502 and Indian Risk
One of the most significant advances in SJS research has been the discovery that genetic markers can predict susceptibility. The HLA-B*1502 allele, a specific variant of a gene involved in immune function, is strongly associated with carbamazepine-induced SJS.
What the Research Shows
A study published in Human Immunology found that HLA-B1502 is a significant risk factor for carbamazepine-induced SJS in the North Indian population. Out of eight SJS patients studied, six carried the HLA-B1502 allele. The association is so strong that the US Food and Drug Administration (FDA) recommends genetic testing for HLA-B*1502 before prescribing carbamazepine to patients of South and Southeast Asian descent.
Prevalence in India
South Asians, including Indians, have an intermediate prevalence of HLA-B*1502, averaging 2-4% of the population. However, certain sub-populations may have higher carrier rates. This means that approximately 2-4 out of every 100 Indians carry this genetic risk factor.
Should You Get Tested?
If your doctor prescribes carbamazepine (or the closely related oxcarbazepine) for epilepsy, trigeminal neuralgia, or bipolar disorder, ask about HLA-B*1502 genetic testing before starting the medication. The test involves a simple blood draw and costs approximately ₹2,000-₹5,000 at major labs in India. It is a one-time test — your HLA status does not change over your lifetime.
Many leading Indian neurologists now routinely order this test before initiating carbamazepine therapy, particularly at tertiary care centres. However, the practice is not yet universal, especially in smaller towns and government hospitals. Being aware of this test empowers you to ask for it proactively.
SJS Cases and Studies in India
India has produced some of the most significant research on SJS in the global medical literature, driven by the condition's relatively high incidence in the Indian population.
Key Indian Studies
Multicentric Retrospective Analysis (IJDVL, 2013): A systematic review covering published Indian data found that antibiotics (37.3%), anti-epileptics (35.7%), and NSAIDs (15.9%) were the three main drug categories responsible. The overall mortality across SJS, SJS-TEN overlap, and TEN was estimated at 12.94%.
ARVO Study on Incidence and Demographics: An 8-year study recorded 908 new SJS patients with an incidence rate of 622 per million population. The study revealed that the incidence was 21% higher in children than adults (731 vs 606 per million). Socioeconomic status was a significant risk factor — people from poorer backgrounds, female homemakers, and unemployed or retired individuals faced higher risk.
Ocular Complications Study (Frontiers in Medicine, 2021): This study from India documented that two-thirds of SJS/TEN patients who present in the chronic phase suffer from severe ocular complications, including permanent vision impairment. Eye damage is one of the most devastating long-term consequences of SJS in India.
Who Is Most Vulnerable in India?
Based on published Indian research, several groups face elevated risk:
- Children: 21% higher incidence than adults, possibly due to more frequent infections and antibiotic use
- People living with HIV/AIDS: Nevirapine and cotrimoxazole — two commonly prescribed antiretroviral drugs — are significant triggers. Nearly 97.6% of HIV-related SJS cases in Indian studies were linked to nevirapine
- Patients starting anti-epileptic therapy: Carbamazepine and phenytoin together account for over 31% of all drug-induced SJS cases in India
- People from lower socioeconomic backgrounds: Possibly due to delayed medical attention, self-medication, and limited access to quality healthcare
- Women: Particularly homemakers, who showed higher susceptibility in demographic analyses
Treatment and Hospital Management
SJS requires immediate hospitalisation, ideally in a burns unit or intensive care unit (ICU) equipped to handle extensive skin loss.
Immediate Steps
- Stop the offending drug immediately — this is the most critical intervention
- Hospital admission — preferably to a burns unit or dermatology ICU
- Fluid and electrolyte replacement — extensive skin loss leads to massive fluid loss, similar to severe burns
- Pain management — SJS is excruciatingly painful; adequate pain control is essential
- Wound care — gentle, non-adhesive dressings; avoid debridement of intact blisters
Medical Treatment
Indian dermatology guidelines (published in IJDVL) recommend:
- Cyclosporine: Has emerged as the most effective treatment, significantly reducing time to arrest progression and total healing time compared to corticosteroids alone
- Intravenous immunoglobulin (IVIG): Used in some centres, though evidence is mixed
- Supportive care: Nutritional support (often via nasogastric tube), temperature regulation, and prevention of secondary infections
Eye Care
Given that ocular complications are the most common long-term consequence, early ophthalmological assessment is critical. Treatment may include:
- Preservative-free lubricating eye drops
- Amniotic membrane transplantation for severe corneal involvement
- Long-term follow-up with an ophthalmologist specialising in ocular surface disease
Recovery Timeline
Recovery from SJS varies widely depending on severity:
| Severity | Typical Hospital Stay | Full Recovery |
|---|---|---|
| Mild SJS (<10% BSA) | 2-4 weeks | 4-8 weeks |
| SJS-TEN Overlap (10-30% BSA) | 3-6 weeks | 2-4 months |
| TEN (>30% BSA) | 4-8+ weeks | 3-6+ months |
Long-term complications can persist for months or years, including skin pigmentation changes, nail abnormalities, chronic dry eyes, and emotional trauma.
How to Protect Yourself and Your Family
While SJS cannot always be prevented, you can significantly reduce your risk with awareness and proactive steps.
Medication Safety Practices
- Keep a detailed medication record: Document every medicine you take, including over-the-counter drugs, and note any adverse reactions. Upload your medical records to MedicalVault to maintain a searchable digital history that you can share with any doctor instantly.
- Inform every doctor about past drug reactions: If you or a family member has ever had a rash, hives, or unusual reaction after a medication, report it to every healthcare provider. This information can be life-saving.
- Ask about HLA-B*1502 testing before starting carbamazepine or oxcarbazepine, especially if you have South or Southeast Asian ancestry.
- Monitor closely when starting new medications: The first 1-4 weeks after beginning any new drug are the highest-risk period for SJS. Watch for fever, rash, mouth sores, or eye redness.
- Never self-medicate with antibiotics: Antimicrobials are the leading cause of drug-induced SJS in India. Antibiotics should only be taken on a doctor's prescription.
Family Health Management
For families managing multiple members' medications — elderly parents on anti-seizure drugs, children receiving antibiotics for infections, or family members living with HIV — centralised medication tracking is essential. Use MedicalVault's family sharing feature to maintain a comprehensive medication and reaction history for every family member, accessible during emergencies.
What to Do If You Suspect SJS
- Stop the suspected medication immediately (but save the packaging for the doctor)
- Go to the nearest hospital emergency department — do not wait for a clinic appointment
- Bring your medication list — or show your MedicalVault report history to the emergency team
- Request burns unit or dermatology ICU admission if skin blistering has begun
- Insist on ophthalmology consultation within the first 24-48 hours
The Importance of Medical Records in SJS Prevention
SJS survivors must carry a documented record of the offending drug for the rest of their lives. Re-exposure to the same drug — or even a chemically related one — can trigger a recurrence that may be more severe than the initial episode.
Paper prescriptions get lost. Verbal warnings get forgotten. A doctor in an emergency room does not have time to call your regular physician to verify your drug allergy history. This is where maintaining digital health records becomes not just convenient but potentially life-saving.
With MedicalVault's digital health records, you can:
- Store your complete medication history and drug allergy alerts
- Share critical allergy information instantly with any healthcare provider via the family sharing feature
- Track your CBC and other blood parameters over time to detect early signs of immune-mediated reactions
- Maintain a family-wide medication safety record using one dashboard
For an in-depth look at why digital health records matter for Indian families, read our guide on digital health records in India.
Key Takeaways
- Stevens-Johnson Syndrome (SJS) is a rare but severe drug reaction that causes skin blistering and can be fatal. India has a notably higher incidence (622 per million) compared to global averages, with an overall SJS/TEN mortality of approximately 12.9%.
- Common Indian medicines are the leading triggers — antibiotics (37.3%), anti-epileptics like carbamazepine and phenytoin (35.7%), and painkillers including paracetamol (15.9%). These are drugs found in almost every Indian home.
- Early warning signs include fever, mouth sores, eye redness, and skin rash appearing 1-3 weeks after starting a new medication. If you notice these symptoms, stop the drug and rush to a hospital immediately.
- Genetic testing (HLA-B*1502) before starting carbamazepine can identify people at high risk. Ask your neurologist about this simple blood test — it costs ₹2,000-₹5,000 and is a one-time, potentially life-saving investment.
- Children, HIV patients, and people from lower socioeconomic backgrounds face higher risk in India. Women, particularly homemakers, also show elevated susceptibility.
- Never self-medicate with antibiotics — they are the single largest category of drugs causing SJS in India. Always take antibiotics only on prescription.
- Maintain a complete digital medication and allergy record on MedicalVault for your entire family. In an emergency, instant access to your drug reaction history could make the difference between life and death.
The best protection against SJS is awareness, cautious medication use, and meticulous record-keeping. Share this article with your family — especially those who manage medications for elderly parents or children. Visit our features page to learn how MedicalVault helps Indian families stay safe with organised, shareable health records.